Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AtriCure stock | $71.37

Learn how to easily invest in AtriCure stock.

AtriCure Inc is a medical instruments & supplies business based in the US. AtriCure shares (ATRC) are listed on the NASDAQ and all prices are listed in US Dollars. AtriCure employs 750 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in AtriCure

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ATRC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

AtriCure stock price (NASDAQ: ATRC)

Use our graph to track the performance of ATRC stocks over time.

AtriCure shares at a glance

Information last updated 2021-10-16.
Latest market close$71.37
52-week range$34.04 - $85.50
50-day moving average $72.98
200-day moving average $74.35
Wall St. target price$96.71
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.28

Buy AtriCure shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AtriCure stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AtriCure price performance over time

Historical closes compared with the close of $71.37 from 2021-10-15

1 week (2021-10-08) 0.69%
1 month (2021-09-17) -6.96%
3 months (2021-07-16) -8.00%
6 months (2021-04-16) 4.96%
1 year (2020-10-16) 75.40%
2 years (2019-10-16) 167.86%
3 years (2018-10-16) 126.07%
5 years (2016-10-14) 330.20%

AtriCure financials

Revenue TTM $243.1 million
Gross profit TTM $149.3 million
Return on assets TTM -3.25%
Return on equity TTM -14.14%
Profit margin -23.31%
Book value $8.39
Market capitalisation $3.3 billion

TTM: trailing 12 months

Shorting AtriCure shares

There are currently 1.0 million AtriCure shares held short by investors – that's known as AtriCure's "short interest". This figure is 10.9% up from 929,409 last month.

There are a few different ways that this level of interest in shorting AtriCure shares can be evaluated.

AtriCure's "short interest ratio" (SIR)

AtriCure's "short interest ratio" (SIR) is the quantity of AtriCure shares currently shorted divided by the average quantity of AtriCure shares traded daily (recently around 193816.54135338). AtriCure's SIR currently stands at 5.32. In other words for every 100,000 AtriCure shares traded daily on the market, roughly 5320 shares are currently held short.

However AtriCure's short interest can also be evaluated against the total number of AtriCure shares, or, against the total number of tradable AtriCure shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AtriCure's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 AtriCure shares in existence, roughly 20 shares are currently held short) or 0.0231% of the tradable shares (for every 100,000 tradable AtriCure shares, roughly 23 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against AtriCure.

Find out more about how you can short AtriCure stock.

AtriCure share dividends

We're not expecting AtriCure to pay a dividend over the next 12 months.

AtriCure share price volatility

Over the last 12 months, AtriCure's shares have ranged in value from as little as $34.04 up to $85.5. A popular way to gauge a stock's volatility is its "beta".

ATRC.US volatility(beta: 1.06)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AtriCure's is 1.0571. This would suggest that AtriCure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

AtriCure overview

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. It offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. The company also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used to treat symptomatic persistent and long-standing persistent atrial fibrillation patients; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, it sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; COBRA Fusion Surgical Ablation System; Fusion Magnetic Retriever System; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company markets and sells its products through independent distributors and direct sales personnel. AtriCure, Inc.

Frequently asked questions

What percentage of AtriCure is owned by insiders or institutions?
Currently 2.899% of AtriCure shares are held by insiders and 98.5% by institutions.
How many people work for AtriCure?
Latest data suggests 750 work at AtriCure.
When does the fiscal year end for AtriCure?
AtriCure's fiscal year ends in December.
Where is AtriCure based?
AtriCure's address is: 7555 Innovation Way, Mason, OH, United States, 45040
What is AtriCure's ISIN number?
AtriCure's international securities identification number is: US04963C2098
What is AtriCure's CUSIP number?
AtriCure's Committee on Uniform Securities Identification Procedures number is: 04963C209

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site